레스베라트롤 시장 동향, 경쟁 구도 및 예측(2033년)

The global resveratrol market is witnessing strong growth due to increasing consumer awareness regarding preventive healthcare, rising demand for natural antioxidants, and expanding applications in dietary supplements, cosmetics, and pharmaceutical products. Resveratrol, a naturally occurring polyphenol known for its antioxidant and anti-inflammatory properties, is gaining significant traction among health-conscious consumers worldwide. The global resveratrol market is expected to be valued at US$11.70 billion in 2026 and is projected to reach US$22.23 billion by 2033, growing at a CAGR of 9.6% between 2026 and 2033.

Market Insights:

The resveratrol market is experiencing notable expansion as consumers increasingly seek plant-based bioactive ingredients that support overall wellness and healthy aging. Growing scientific research highlighting the potential benefits of resveratrol in cardiovascular health, cognitive function, and anti-aging applications is encouraging product innovation across multiple industries. Manufacturers are focusing on developing high-purity formulations and incorporating resveratrol into functional foods, nutraceuticals, skincare products, and pharmaceutical formulations. Technological advancements in extraction methods and biotechnology-based production are also improving product quality and commercial scalability.

Drivers:

Key drivers of the resveratrol market include the rising prevalence of chronic diseases, increasing demand for natural dietary supplements, and growing consumer preference for clean-label and plant-derived ingredients. The expanding aging population is driving demand for anti-aging products enriched with resveratrol due to its antioxidant properties. Increasing awareness of preventive healthcare, coupled with rising disposable incomes and greater investment in wellness products, is further supporting market growth. Additionally, continuous research into the therapeutic potential of resveratrol is expanding its pharmaceutical applications.

Business Opportunity:

The market presents substantial business opportunities for companies investing in innovative nutraceutical formulations, premium skincare products, and pharmaceutical research involving resveratrol. Emerging economies offer significant growth potential due to improving healthcare awareness, expanding retail distribution channels, and increasing demand for functional health products. Manufacturers can also capitalize on the growing popularity of personalized nutrition and functional beverages by incorporating resveratrol into new product categories. Strategic partnerships, biotechnology innovations, and sustainable sourcing practices are expected to create additional competitive advantages in the coming years.

Region Analysis:

North America dominates the resveratrol market owing to high consumer awareness, strong demand for dietary supplements, and a well-established nutraceutical industry. Europe follows closely, supported by increasing preference for natural health products, favorable regulatory standards, and growing adoption of anti-aging skincare solutions. The Asia Pacific region is expected to register the fastest growth during the forecast period due to rising healthcare expenditure, expanding middle-class population, increasing demand for herbal supplements, and rapid growth of the cosmetics industry. Latin America and the Middle East & Africa are also witnessing gradual market expansion, driven by improving healthcare infrastructure, rising wellness trends, and growing availability of nutritional supplements.

Key Players:

• SkinCeuticals (L'Oreal Group)
• Evolva SA
• DSM Nutritional Products / dsm-firmenich
• Jeunesse Global
• VitaMonk
• Helix Healthstore
• Terraternal
• Andorra Life
• ResVitale, LLC
• Endurance Products Company

Segmentation:

By Application

• Cosmetics
• Dietary Supplements
• Pharmaceutical

By Dosage Form

• Tablet
• Capsule
• Liquid

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Resveratrol Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2026
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. COVID-19 Impact Analysis
• 2.5. Porter's Five Forces Analysis
• 2.6. Impact of Russia-Ukraine Conflict
• 2.7. PESTLE Analysis
• 2.8. Regulatory Analysis
• 2.9. Price Trend Analysis
  • 2.9.1. Current Prices and Future Projections, 2025-2033
  • 2.9.2. Price Impact Factors

3. Global Resveratrol Market Outlook, 2020-2033

• 3.1. Global Resveratrol Market Outlook, by Application, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 3.1.1. Cosmetics
  • 3.1.2. Dietary Supplements
  • 3.1.3. Pharmaceutical
• 3.2. Global Resveratrol Market Outlook, by Dosage Form, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 3.2.1. Tablet
  • 3.2.2. Capsule
  • 3.2.3. Liquid
• 3.3. Global Resveratrol Market Outlook, by Region, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 3.3.1. North America
  • 3.3.2. Europe
  • 3.3.3. Asia Pacific
  • 3.3.4. Latin America
  • 3.3.5. Middle East & Africa

4. North America Resveratrol Market Outlook, 2020-2033

• 4.1. North America Resveratrol Market Outlook, by Application, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 4.1.1. Cosmetics
  • 4.1.2. Dietary Supplements
  • 4.1.3. Pharmaceutical
• 4.2. North America Resveratrol Market Outlook, by Dosage Form, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 4.2.1. Tablet
  • 4.2.2. Capsule
  • 4.2.3. Liquid
• 4.3. North America Resveratrol Market Outlook, by Country, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 4.3.1. U.S. Resveratrol Market Outlook, by Application, 2020-2033
  • 4.3.2. U.S. Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 4.3.3. Canada Resveratrol Market Outlook, by Application, 2020-2033
  • 4.3.4. Canada Resveratrol Market Outlook, by Dosage Form, 2020-2033
• 4.4. BPS Analysis/Market Attractiveness Analysis

5. Europe Resveratrol Market Outlook, 2020-2033

• 5.1. Europe Resveratrol Market Outlook, by Application, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 5.1.1. Cosmetics
  • 5.1.2. Dietary Supplements
  • 5.1.3. Pharmaceutical
• 5.2. Europe Resveratrol Market Outlook, by Dosage Form, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 5.2.1. Tablet
  • 5.2.2. Capsule
  • 5.2.3. Liquid
• 5.3. Europe Resveratrol Market Outlook, by Country, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 5.3.1. Germany Resveratrol Market Outlook, by Application, 2020-2033
  • 5.3.2. Germany Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 5.3.3. Italy Resveratrol Market Outlook, by Application, 2020-2033
  • 5.3.4. Italy Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 5.3.5. France Resveratrol Market Outlook, by Application, 2020-2033
  • 5.3.6. France Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 5.3.7. U.K. Resveratrol Market Outlook, by Application, 2020-2033
  • 5.3.8. U.K. Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 5.3.9. Spain Resveratrol Market Outlook, by Application, 2020-2033
  • 5.3.10. Spain Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 5.3.11. Russia Resveratrol Market Outlook, by Application, 2020-2033
  • 5.3.12. Russia Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 5.3.13. Rest of Europe Resveratrol Market Outlook, by Application, 2020-2033
  • 5.3.14. Rest of Europe Resveratrol Market Outlook, by Dosage Form, 2020-2033
• 5.4. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Resveratrol Market Outlook, 2020-2033

• 6.1. Asia Pacific Resveratrol Market Outlook, by Application, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 6.1.1. Cosmetics
  • 6.1.2. Dietary Supplements
  • 6.1.3. Pharmaceutical
• 6.2. Asia Pacific Resveratrol Market Outlook, by Dosage Form, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 6.2.1. Tablet
  • 6.2.2. Capsule
  • 6.2.3. Liquid
• 6.3. Asia Pacific Resveratrol Market Outlook, by Country, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 6.3.1. China Resveratrol Market Outlook, by Application, 2020-2033
  • 6.3.2. China Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 6.3.3. Japan Resveratrol Market Outlook, by Application, 2020-2033
  • 6.3.4. Japan Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 6.3.5. South Korea Resveratrol Market Outlook, by Application, 2020-2033
  • 6.3.6. South Korea Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 6.3.7. India Resveratrol Market Outlook, by Application, 2020-2033
  • 6.3.8. India Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 6.3.9. Southeast Asia Resveratrol Market Outlook, by Application, 2020-2033
  • 6.3.10. Southeast Asia Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 6.3.11. Rest of SAO Resveratrol Market Outlook, by Application, 2020-2033
  • 6.3.12. Rest of SAO Resveratrol Market Outlook, by Dosage Form, 2020-2033
• 6.4. BPS Analysis/Market Attractiveness Analysis

7. Latin America Resveratrol Market Outlook, 2020-2033

• 7.1. Latin America Resveratrol Market Outlook, by Application, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 7.1.1. Cosmetics
  • 7.1.2. Dietary Supplements
  • 7.1.3. Pharmaceutical
• 7.2. Latin America Resveratrol Market Outlook, by Dosage Form, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 7.2.1. Tablet
  • 7.2.2. Capsule
  • 7.2.3. Liquid
• 7.3. Latin America Resveratrol Market Outlook, by Country, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 7.3.1. Brazil Resveratrol Market Outlook, by Application, 2020-2033
  • 7.3.2. Brazil Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 7.3.3. Mexico Resveratrol Market Outlook, by Application, 2020-2033
  • 7.3.4. Mexico Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 7.3.5. Argentina Resveratrol Market Outlook, by Application, 2020-2033
  • 7.3.6. Argentina Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 7.3.7. Rest of LATAM Resveratrol Market Outlook, by Application, 2020-2033
  • 7.3.8. Rest of LATAM Resveratrol Market Outlook, by Dosage Form, 2020-2033
• 7.4. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Resveratrol Market Outlook, 2020-2033

• 8.1. Middle East & Africa Resveratrol Market Outlook, by Application, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 8.1.1. Cosmetics
  • 8.1.2. Dietary Supplements
  • 8.1.3. Pharmaceutical
• 8.2. Middle East & Africa Resveratrol Market Outlook, by Dosage Form, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 8.2.1. Tablet
  • 8.2.2. Capsule
  • 8.2.3. Liquid
• 8.3. Middle East & Africa Resveratrol Market Outlook, by Country, Value (US$ Bn) & Volume (Tons), 2020-2033
  • 8.3.1. GCC Resveratrol Market Outlook, by Application, 2020-2033
  • 8.3.2. GCC Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 8.3.3. South Africa Resveratrol Market Outlook, by Application, 2020-2033
  • 8.3.4. South Africa Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 8.3.5. Egypt Resveratrol Market Outlook, by Application, 2020-2033
  • 8.3.6. Egypt Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 8.3.7. Nigeria Resveratrol Market Outlook, by Application, 2020-2033
  • 8.3.8. Nigeria Resveratrol Market Outlook, by Dosage Form, 2020-2033
  • 8.3.9. Rest of Middle East Resveratrol Market Outlook, by Application, 2020-2033
  • 8.3.10. Rest of Middle East Resveratrol Market Outlook, by Dosage Form, 2020-2033
• 8.4. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Company Vs Segment Heatmap
• 9.2. Company Market Share Analysis, 2025
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. SkinCeuticals
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Developments
  • 9.4.2. Evolva SA
  • 9.4.3. DSM Nutritionals
  • 9.4.4. Jeunesse Global
  • 9.4.5. VitaMonk
  • 9.4.6. Helix Healthstore
  • 9.4.7. Terraternal
  • 9.4.8. Andorra Life
  • 9.4.9. ResVitale, LLC
  • 9.4.10. Endurance Products Company
  • 9.4.11. RevGenetics
  • 9.4.12. SiChuan Xieli Pharmaceutical Co., Ltd

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations